Wholesale USA peptides.
From inside the industry.
the next lab is the wholesale arm of a working research-peptide operation — we run our own RUO brand on the same supply. The offer is one offer, three lanes: white-label fulfillment under the buyer's label with no minimum, wholesale by the case from $1,500 [LA same-day domestic, Hong Kong worldwide], and the marketing house [storefront, processor, compliance]. Payments rides every lane rather than being one. This desk is your reference: what we sell, what it costs, and how to talk about it.
"Everyone else sells you vials. We sell you the part you do not want to run. Your name on the vial with nothing on your shelf, fulfilled out of Los Angeles and plugged straight into your store. Research peptides by the case when you want to hold stock. Plus the two things nobody else hands you — a payment path through a bank that underwrites this category, and a storefront built to survive in it. Every claim we make ships with a document."
Everything we sell is Research Use Only — not for human consumption. Never claim or imply human use, dosing, or benefit — in writing, on calls, anywhere. The full non-negotiables are in Sell it. Compliance is the moat that keeps our doors open and your commissions flowing.
The industry, honestly.
You're selling into a market with real, specific problems. Learn them — every one of them is the reason a buyer picks up the phone.
- Most supply is untested gray-market import. No third-party testing, no lot tracking, no paperwork when a customer asks. Buyers know this — it's their single biggest anxiety, and it's why a COA library closes deals.
- The category can't run mainstream paid ads. Brands grow on communities, organic, and email — so a brand's reputation is its entire acquisition engine. One bad batch is existential for them. That's the fear you're actually selling against.
- Payments are fragile. Card processors routinely drop peptide merchants. At wholesale, wire/ACH invoicing is the norm — nobody serious is asking to run a card.
- September 2025: FDA warning letters went to sellers marketing RUO peptides with human-use implications — BPC-157 and GLP compounds included. The letters targeted the marketing language, not the molecules. Sloppy copy got hit; disciplined RUO sellers didn't. That's why our compliance line is absolute.
- We operate in this category ourselves. Our own RUO brand runs on the same factory relationship, the same third-party certificates, the same LA fulfillment. The wholesale arm sells what we already use — we're operators, not brokers flipping vials.
- The big wholesale books gate pricing behind committed volume. Per the July 2026 schedules: the in-stock lane starts at $25K monthly committed with rebate true-ups; the cheaper lane is made-to-order — COD with a 30–50% production deposit and a 2–4 week lead.
- Our book has one tier and it opens at $1,500. No monthly commitment to unlock a price, and white label opens at a single vial. On the flagship SKUs we run well under their $25K entry pricing — in stock, no deposit, no lead time, no true-up math.
- The honest exception: Epithalon 50mg — the committed books run it below our cost, so we lose that one on price. Don't lead with it; lead with the other 73 SKUs.
This is the biggest wellness wave in a decade, and it's early. The reps who grow accounts fastest are the ones who can show a buyer where the money is actually going — and why sitting still is the expensive choice.
The account that orders one hero SKU is leaving money on the table while the wave is cresting. The move is to widen the SKU mix [metabolic pulls them in; recovery and longevity are the repeat-margin attach] and put them on a standing order so they never go dry mid-wave. Frame it as theirs to lose: "the demand is already in your audience — the only question is whether they buy it from you or from someone with worse supply. Let's make sure you're never the one out of stock."
Market figures are directional [analyst consensus, branded-drug category] — use them to size the opportunity, never as a claim about our product. Everything we sell stays RUO.
That's the whole sell: a category the market is pouring money into, tested supply that's in stock with no commitment, sold by people inside the industry. You don't need to hype anything — the demand and the buyer's own problems do the talking. Your job is to know both better than they do.
Onboarding the sales manager.
This is the checklist for bringing a sales manager onto the desk — currently Ari. Paperwork first, access second, product knowledge third. Nobody quotes a buyer before all three are done.
The six things to know cold
How the pay works
8% of gross sales
- Gross sales = collected, net of refunds, chargebacks, shipping and tax
- Residuals run during the term only — they end at termination
- Paid monthly, by the 15th, on the prior month's collections
- Compliance breach forfeits commission on the affected revenue
5% then 2%
- 5% of the recruited affiliate's first $50k of attributed net sales
- 2% uncapped above $50k, within a six-month attribution window
- One level deep only — no overrides on someone else's recruits
- $500 dust filter; no double-dip between B2B and affiliate revenue
No portal admin. No visibility into base cost — ever, to anyone. No authority to set custom pricing: the standard book is wholesale plus 15%, and any deviation is a management decision, not a rep's. Quote from the portal, every time. Volume is the strategy — a hundred thin accounts beat ten fat ones, and discounting to win one deal teaches the market the wrong number.
Goal: pipeline built, first discovery calls booked, zero compliance missteps.
Goal: first revenue on the board; a repeatable rhythm.
Goal: recurring residual income; predictable pipeline; the outline of the team that scales it.
8% of gross sales on B2B wholesale and white label — one rate, first order and every reorder from accounts you own. Weighted toward residual income: you get paid every month an account keeps buying. Gross sales means collected revenue, net of refunds, chargebacks, shipping and tax [we invoice wire/ACH; new accounts prepay — you earn when the money lands]. Compliance is a condition of getting paid. Full detail, including the affiliate override, is in Onboarding & pay.
Nothing on this page authorizes any human-use, dosing, or therapeutic claim. All products are Research Use Only — not for human consumption.
Live per-account pricing lives at portal.thenextlab.co — always quote from the portal.